secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2022-07-07T23:59:59+00:00
Accession:  0000950170-22-012519
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo pre-announces Q2 revenue $3.4-3.6M, up 10-16% YoY; record pipeline adds
-----------------------------------------------------------------------------

- Preliminary Q2 2022 revenue $3.4–$3.6M, up 10–16% vs Q2 2021; all product revenue.
- Added >400 prospective MyoPro patients in Q2, a quarterly record; cost per pipeline add decreased.
- Second JV license fee payment from China partner delayed due to COVID-19 banking/government backlog.
- Participated in CMS public hearing for Benefit Category Determination to reclassify MyoPro as custom-fabricated brace.
- Full Q2 results and conference call scheduled for August 3, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017022012519/0000950170-22-012519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017022012519/myo-20220707.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-012519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer